论文部分内容阅读
[目的]观察在中西医结合治疗重症急性胰腺炎(SAP)的基础上,早期应用生长抑素的临床疗效。[方法]将72例SAP患者随机分为生长抑素治疗组40例和对照组32例,两组均予中西医结合治疗,治疗组加用生长抑素250μg/h持续微泵泵入,持续5~7 d,对两组之间腹痛及压痛缓解、多项实验室指标、腹水消失、住院时间以及并发症发生率、转手术率、病死率进行分析。[结果]治疗组腹痛及压痛缓解时间、实验室指标恢复时间、腹水消失、住院时间等明显优于对照组(P<0.05,<0.01),并发症发生、转手术率及病死率低于对照组(P<0.05)。[结论]早期中西医结合联合生长抑素对SAP治疗有重要价值。
[Objective] To observe the clinical effect of early application of somatostatin on the basis of integrated traditional Chinese and western medicine in the treatment of severe acute pancreatitis (SAP). [Methods] Seventy-two patients with SAP were randomly divided into 40 cases of somatostatin treatment group and 32 cases of control group. Both groups were treated with combination of TCM and Western medicine. The treatment group was treated with continuous microgas pump with somatostatin 250μg / h, Between 5 and 7 days, abdominal pain and tenderness relief, multiple laboratory indexes, disappearance of ascites, length of hospital stay, complication rate, operation rate and mortality were analyzed. [Results] The pain relief time, the recovery time of laboratory indexes, the disappearance of ascites and the length of hospital stay in the treatment group were significantly better than those in the control group (P <0.05, <0.01). Complications, morbidity and mortality were lower than those in the control group Group (P <0.05). [Conclusion] The early combination of traditional Chinese and western medicine with somatostatin has important value in the treatment of SAP.